Sep 4, 2026 08:00AM
Apr 22, 2026 06:42AM
Aug 29, 2025 08:30AM
Aug 19, 2025 06:37AM
Jun 3, 2025 07:05AM
May 9, 2025 07:01AM
Jul 1, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
Mar 1, 2024 05:00PM
Mar 1, 2024 05:00PM
Feb 20, 2024 01:59PM
Apr 24, 2023 07:01AM
Apr 24, 2023 07:01AM
Mar 1, 2023 08:03AM
Mar 1, 2023 08:03AM Iovance Biotherapeutics to Present at Upcoming Conferences
Sep 6, 2022 04:01PM
Sep 6, 2022 04:01PM
Mar 8, 2021 06:06AM
Mar 1, 2021 04:01PM
Mar 1, 2021 04:01PM
Jun 2, 2020 04:01PM
Jun 2, 2020 04:01PM Iovance Biotherapeutics, Inc. Announces Closing of $603.7 Million Common Stock Public Offering
May 29, 2020 05:52AM
May 28, 2020 09:30PM
May 28, 2020 09:30PM
Feb 26, 2020 07:10AM
Aug 26, 2019 04:30PM
Aug 26, 2019 04:30PM
Jun 3, 2019 07:29AM Iovanace Biotherapeutics (IOVA) PT Raised to $32 at H.C. Wainwright; 'TILs Continue to Shine at ASCO'
Mar 29, 2019 08:23AM
Sep 6, 2018 08:25AM
Aug 29, 2018 08:01AM
Aug 29, 2018 08:01AM
Jan 25, 2018 07:18AM
Sep 25, 2017 04:01PM
Sep 21, 2017 05:53AM Iovance Biotherapeutics (IOVA) Prices 7.692M Share Common Offering at $6.50/Sh
Sep 20, 2017 06:07PM

22,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All